Adapting to Manufacturing Disruption: A Strategic Life Sciences Webinar Series
QAD
JANUARY 27, 2021
Pre-commercial life science manufacturers, including medical device manufacturers, biotech companies, and contract manufacturing organizations (CMOs), face infrastructure challenges as they work toward Food and Drug Administration (FDA) approval. Click below to watch a replay of this webinar. . Silos in a GMP environment can be risky.
Let's personalize your content